GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,771,443 | -86.1% | 138,656 | -72.6% | 0.01% | -74.1% |
| Q3 2022 | $27,210,210 | +30.8% | 505,488 | -2.0% | 0.05% | +38.5% |
| Q2 2022 | $20,806,121 | -40.0% | 515,772 | -1.5% | 0.04% | -20.4% |
| Q1 2022 | $34,690,275 | +28.3% | 523,710 | +93.8% | 0.05% | -29.0% |
| Q4 2021 | $27,028,000 | -17.9% | 270,221 | +2.7% | 0.07% | -25.0% |
| Q3 2021 | $32,903,000 | -1.0% | 263,200 | -1.6% | 0.09% | +91.7% |
| Q2 2021 | $33,232,000 | +118.9% | 267,592 | +169.0% | 0.05% | +4.3% |
| Q1 2021 | $15,183,000 | +20.7% | 99,461 | +1.9% | 0.05% | +17.9% |
| Q4 2020 | $12,581,000 | +20.1% | 97,617 | +4.2% | 0.04% | +2.6% |
| Q3 2020 | $10,472,000 | -35.1% | 93,681 | -52.9% | 0.04% | +18.8% |
| Q2 2020 | $16,142,000 | +37.1% | 198,960 | +17.6% | 0.03% | +10.3% |
| Q1 2020 | $11,772,000 | – | 169,152 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |